Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Libera Bio
Krakow, Poland
B
- Employees
2018
Key takeaway
Libera Bio is a biopharmaceutical company focused on developing innovative therapeutics for cancer, particularly targeting intracellular disease mechanisms. Their advanced MPN Technology® allows for the delivery of large molecules like antibodies, which could enhance treatment strategies in oncology.
Reference
Core business
Libera Bio | Addressing undruggable intracellular targets in oncology
Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Mabion S.A.
Konstantynów Łódzki, Poland
B
251-500 Employees
2007
Key takeaway
The company highlights its expertise in addressing client needs and overcoming challenges, particularly in the context of CAR-T cell therapy. They are involved in the investigation of all registered CAR-T products, which are essential for treating relapsed and treatment-resistant hematologic malignancies.
Reference
Core business
Home page - Mabion
OncoTherics
Krakow, Poland
B
1-10 Employees
2009
Key takeaway
OncoTherics Limited focuses on developing therapies that target hypoxic micro-environments in tumors, which are often resistant to conventional treatments like chemotherapy and radiotherapy. Their research could be particularly relevant to advancements in CAR-T cell therapy, as it addresses therapy-resistant cancer cells.
Reference
Core business
Home | OncoTherics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Genegoggle
Warsaw, Poland
B
11-50 Employees
-
Key takeaway
Genegoggle is a precision medicine biotech company focused on enhancing human health through innovative therapeutics and advanced genomic understanding. Their expertise in epigenetics and computational biology may contribute to the development of novel therapies, potentially including CAR-T cell therapy applications.
Reference
Service
Services | Genegoggle
Zettagene
Warsaw, Poland
B
1-10 Employees
2019
Key takeaway
Zettagene is a genomics company that provides bioinformatics services and solutions to accelerate research and clinical diagnostics. Their expertise in genomics and data science positions them to support advancements in CAR-T cell therapy and related fields.
Reference
Core business
Zettagene - An applicable genomics company
Bioceltix sp. z o.o.
Wrocław, Poland
B
1-10 Employees
2016
Key takeaway
W Bioceltix, we are developing innovative biological drugs based on stem cells, aiming to transform therapeutic standards in veterinary medicine.
Reference
Core business
Strona główna - Bioceltix
Zmieniamy standardy terapii w weterynarii Tworzymy innowacyjne leki biologiczne w oparciu o komórki macierzyste Rozwijane leki biologiczne
Clinical Consulting Poland
Tychy, Poland
B
11-50 Employees
2004
Key takeaway
The company offers specialized clinical trial management services that could be beneficial for the development and implementation of CAR-T cell therapies. Their expertise in complex trial designs and commitment to quality data delivery ensures that biotech and pharmaceutical companies receive the support needed for successful clinical outcomes.
Reference
Service
EMA Orphan Drug Designation – Clinical Consulting
BVI
Gdańsk, Poland
B
1-10 Employees
-
Key takeaway
The BioVentures Institute Ltd. specializes in advanced genetic engineering and molecular biotechnology, with a focus on developing innovative products and technologies, including applications in biomedical fields. Their expertise in DNA recombination and the development of specialized kits for isolating RNA, DNA, and proteins suggests a strong foundation in the underlying science relevant to CAR-T cell therapy.
Reference
Core business
Bioventures Institute - Molecular Biotechnology Company
The BioVentures Institute Ltd. is an innovation-driven molecular biotechnology company, conducting applied research, product development and production, utilizing advanced genetic engineering, molecular biology, biochemical and microbiological technologies.
FiberTeam Photonic Solutions
Lublin, Poland
B
1-10 Employees
2021
Key takeaway
LabtechCO is a medical testing laboratory service that collaborates with leading research institutions, offering a comprehensive range of tests for diagnosis and evaluation. Their expertise in hematology and other specialized testing may complement advancements in CAR-T cell therapy.
Reference
Service
Our Services – FiberTeam Photonic Solutions
Celther Polska
Zakroczym, Poland
B
11-50 Employees
2008
Key takeaway
CELTHER POLSKA is a biotechnology and medical company conducting advanced research in molecular biology and cell engineering.
Reference
Product
Shecell innovation lab 30+ – celther.com
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T Cell Therapy industry in Poland, several key considerations emerge. The regulatory landscape is crucial, as CAR-T therapies must adhere to stringent European Medicines Agency (EMA) guidelines and local health authority requirements. Understanding these regulations can significantly impact the speed of product development and approval. Additionally, the industry faces challenges such as high production costs and the complexity of personalized therapies. There are, however, substantial opportunities for growth, given Poland's advancing research capabilities and increasing investments in biotechnology. The competitive landscape includes both established pharmaceutical companies and emerging biotech firms, each striving to innovate within this specialized market. Furthermore, Poland's integration into the European Union allows for easier collaboration with research institutions across Europe, enhancing the potential for successful partnerships. Environmental concerns related to the manufacturing processes are also relevant, particularly regarding waste management and sustainability practices. The global market for CAR-T therapies is expanding, with Poland positioned as a promising player in this field. As the demand for personalized medicine rises, understanding these factors will be essential for anyone interested in entering the CAR-T Cell Therapy sector in Poland.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Poland |
| Amount of fitting manufacturers | 27 |
| Amount of suitable service providers | 21 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2004 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of CAR-T Cell Therapy?
Start-Ups who are working in CAR-T Cell Therapy are FiberTeam Photonic Solutions
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are IT, Software and Services, Biotechnology, Other, Pharmaceuticals, Healthcare
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.